Business
Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026
PARIS & BOSTON, March 11, 2026--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today proudly announces that the CLIMB study (Confocal Laser Endomicroscopy as an IMaging Biomarker, ClinicalTrials.gov ID: NCT03492151) will be presented at the ASGE (American Society for Gastrointestinal Endoscopy) Presidential Plenary Session on Sunday, May 3, 2026, one of the most
About this update from Mauna Kea Technologies Sa Class O
[{"type":"text","content":"ASGE Presidential Plenary Session highlights the most impactful endoscopy research selected from thousands of submissions to Digestive Disease Week","length":147,"tagName":"p","attribs":{}},{"type":"text","content":"PARIS & BOSTON, March 11, 2026--(BUSINESS WIRE)--Regulatory News:","length":69,"tagName":"p"},{"type":"text","content":"Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today proudly announces that the CLIMB study (Confocal Laser Endomicroscopy as an IMaging Biomarker, ClinicalTrials.gov ID: NCT03492151) will be presented at the ASGE (American Society for Gastrointestinal Endoscopy) Presidential Plenary Session on Sunday, May 3, 2026, one of the most prestigious sessions of the Digestive Disease Week (DDW) 2026 conference, to be held from May 2 to 5, 2026 in Chicago, Illinois.","length":580,"tagName":"p"},{"type":"text","content":"This prospective multicenter study (over 500 patients across 14 U.S. centers) led by Dr. Somashekar (Som) Krishna, Professor of Medicine and Director of Advanced Endoscopy at The Ohio State University Wexner Medical Center, demonstrates the superiority of EUS-nCLE (Endoscopic Ultrasound-guided needle-based Confocal Laser Endomicroscopy using Cellvizio) for the multimodal diagnosis of pancreatic cystic lesions (PCLs), particularly IPMNs (intraductal papillary mucinous neoplasms), a common type of premalignant or malignant cyst. EUS-nCLE confirms unmatched diagnostic accuracy compared to standard methods (cyst fluid analysis: CEA, amylase, cytology, glucose), thanks to accurate cellular-level visualization which can improve patient management and outcomes.","length":764,"tagName":"p"},{"type":"text","content":"This selection for the ASGE Presidential Plenary Session highlights the major clinical impact of Cellvizio and positions it as a key tool for the evolution of PCL management.","length":174,"tagName":"p"},{"type":"text","content":"Dr. Krishna and his team illustrate academic excellence surrounding Cellvizio with 9 accepted works (6 lectures, 3 posters) covering:","length":133,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Precise real-time diagnosis (e.g., serous cystadenomas) and reduction of inappropriate surgeries via multimodal approaches;...